LSTA:NASDAQ
Lisata Therapeutics Inc
$1.52
arrow_downward
-1.30%(-0.020) 1D
Sep 16, 12:36:19 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LSTA...
Open
$1.53
High
$1.56
Low
$1.49
Mkt. cap
13.70M
Avg. vol.
395.14K
Volume
13.11K
52-wk high
$5.06
52-wk low
$0.99
EPS
-$1.64
Beta
0.94
Shares outstanding
9.01M
No. of employees
21
Open
$1.53
High
$1.56
Low
$1.49
Mkt. cap
13.70M
Avg. vol.
395.14K
Volume
13.11K
52-wk high
$5.06
52-wk low
$0.99
EPS
-$1.64
Beta
0.94
Shares outstanding
9.01M
No. of employees
21
Profile
Lisata Therapeutics is an American clinical stage pharmaceutical company active in the field of oncology, specifically aimed at developing and commercializing new cancer therapies. It was formed through a merger of Cend Therapeutics and Caladrius Biosciences in September 2022.
In 2019, the FDA granted their product, certepetide, orphan drug status in pancreatic cancer, followed by a Fast track status in 2022. Non-clinical data collected by Lisata and others have demonstrated enhanced delivery of various existing and emerging anti-cancer therapies, including chemotherapies, immunotherapies and RNA-based therapeutics when used with certepetide. Wikipedia
About Lisata Therapeutics Inc
CEO-
Employees21
Founded1980
HeadquartersBasking Ridge, New Jersey, United States
SectorBiotechnology
Websitelisata.com